Navigation Links
Mersana Therapeutics Appoints Michael A. Metzger as EVP & COO
Date:4/20/2011

anchise. He also led the US co-development and co-promotion deal with Ironwood Pharmaceuticals for Linaclotide. Prior to Forest, Mr. Metzger was Vice President of Corporate Development at Onconova Therapeutics, where he was responsible for the company's business development and financial initiatives. He also served as Managing Director at MESA Partners, a venture capital firm focused on healthcare and IT companies. He serves as a member of the Board of Directors and Chairman of the Finance Committee of Response Genetics, Inc., a company focused on the development and commercialization of molecular diagnostic tests for cancer. Mr. Metzger earned his BA from George Washington University and an MBA in Finance from New York University's Stern School of Business.

About Mersana Therapeutics, Inc.

Mersana, a privately held, venture backed company, utilizes its proprietary polymer conjugate platform, called  Fleximer®, to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties. The key component of Mersana's Fleximer platform is a novel, biodegradable and bio-inert material that can be chemically linked to small molecules and biologics. Mersana's clinical pipeline includes XMT-1001, a Fleximer-camptothecin conjugate, which is currently in Phase 1b clinical trials, as well as XMT-1107, a conjugate of Fleximer and a novel analog of fumagillin, which is currently in Phase 1 clinical trials and partnered on a worldwide basis with Teva Pharmaceuticals. Mersana's investors include Fidelity Biosciences, ProQuest Investments, Rho Ventures, Harris & Harris Group and PureTech Ventures.

Fleximer® is a trademark of Mersana Therapeutics, Inc.


'/>"/>
SOURCE Mersana Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
2. Mersana Therapeutics Provides Clinical Update from Ongoing Phase 1 Study of XMT-1001 in Patients with Advanced Solid Tumors
3. Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference
4. Amicus Therapeutics Announces Transition of John F. Crowley from Chairman and Chief Executive Officer to Executive Chairman
5. CoDa Therapeutics Closes $19 Million Series B Financing Round
6. Reportlinker Adds Endometrial Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Bone Metastases Therapeutics - Pipeline Assessment and Market Forecasts to 2017
8. Reportlinker Adds Juvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
9. Oxford BioTherapeutics Licenses BioWas POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer
10. Medicomp, Inc. Announces Company Purchase From United Therapeutics
11. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2013 through 2020. Also, a ...
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report ... Animals. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:9/16/2014)... , Sept. 16, 2014  ROX Medical ... an international multi-center, prospective, randomized, controlled, blinded endpoint ... of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the ... a fixed connection between a central artery and ... treatment of hypertension. The primary outcomes are reduction ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11
(Date:9/16/2014)... UWDress.com, the well-known wedding dress manufacturer and retailer, ... assortment online. Additionally, the firm has launched a promotion ... discounts now, up to 62 percent off. ... it has won a lot of positive reviews for ... also providing big savings on many other items, including ...
(Date:9/16/2014)... Pulmonary Hypertension Association Travels to San Diego for PHA ... and Families to Help Fight Rare Lung Disease , Who:, ... hypertension association that works to find ways to prevent and ... that affects the functioning of the heart and can lead ... 2.8 years. , What:, PHA On The Road ...
(Date:9/16/2014)... Paradigm Physical Therapy is proud to announce ... for their patients. Dry needling is a procedure that ... musculoskeletal problems. , In this invasive procedure, a solid ... and muscle to create a trigger point. Using repeated ... to deactivate and release the trigger point within seconds. ...
(Date:9/16/2014)... electronic activity monitors hold great promise in helping ... These increasingly sophisticated devices help the wearers improve ... bodily responses. This information is organized into companion ... the large and quickly growing market for these ... Branch at Galveston analyzed 13 of these activity ...
(Date:9/16/2014)... September 14, 2014 A new clinical ... (EES) and drug-eluting balloons (DEB) in treating ... that EES provided superior late angiographic results ... Findings were reported today at the 26th ... Sponsored by the Cardiovascular Research Foundation (CRF), ...
Breaking Medicine News(10 mins):Health News:New Elegant Evening Wear Assortment Released By UWDress.com 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Paradigm Physical Therapy Introduces Dry Needling 2Health News:Do wearable lifestyle activity monitors really work? 2Health News:Do wearable lifestyle activity monitors really work? 3Health News:Results of RIBS IV trial reported at TCT 2014 2
... HARBIN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... CSKI ), a,leading fully integrated pharmaceutical company ... today announced the launch of,its new corporate website under ... The new website features an expanded ...
... 11 An insidious illness is stealing the vitality of ... closely mirror those of other conditions, it is frequently misdiagnosed, ... know they could prevent the condition, known as systemic Candida, ... Now Kathleen Kalaf, founder and president of the non-profit ...
... localized disease, research shows , TUESDAY, Aug. 11 ... in advanced prostate cancer patients but doesn,t reduce the ... researchers say. , They reported on the long-term survival ... trials launched in 1994. The trials examined the effects ...
... ... a two year partnership with XtremeSportsID™. The NBCF edition of the interactive emergency identification ... fulfill the NBCF mission to save lives through early detection and awareness. , ... Lahaina, HI (PRWEB) August ...
... , BALTIMORE, Aug. 11 , , To ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NY59748LOGO ) , , News Facts ... created an engaging, first-of-its-kind Web-based series called the L e ... journalist Carol Martin . The resource brings together medical doctors, nurses, psychologists, ...
... , RESEARCH TRIANGLE PARK, N.C., Aug. 11 ... today announced the completion of a $16.1 million Series E ... Alta Partners, Sanderling Ventures and Asset Management Company participated in ... Proceeds from the financing will primarily be used to expand ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Launches New Corporate Website 2Health News:China Sky One Medical, Inc. Launches New Corporate Website 3Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 2Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 3Health News:Oral Drug Ups Survival in Advanced Prostate Cancer Cases 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 2Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 4Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 5Health News:Chimerix Raises $16.1 Million in Series E Financing 2
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
... Liquichek ToRCH Plus IgM Controls ... problems in your ToRCH IgM ... your test results. Liquichek ToRCH ... perfect complement to Liquichek ToRCH ...
... Plus Control is a bilevel ... the performance of the most ... assays. A weak positive and ... to monitor the performance of ...
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests....
Medicine Products: